Pomalidomide Supplier-Buyer Network — Trade Flow Analysis

Name: Pomalidomide Supplier-Buyer Trade Network Dataset — 108+ Indian Exporters, 10+ Importers, 52+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Pomalidomide supplier network, Pomalidomide buyers, pharmaceutical export India, Pomalidomide trade data

TransData Nexus

Pomalidomide

India Pharmaceutical Trade Intelligence

$4.4M108 Suppliers52 CountriesHS 30049099

ExportsIndia → COLOMBIA50.5%India → UNITED ARAB25.1%

ImportsUNITED STATES → India$1.8M BELGIUM → India$308.1K

#1 Supplier: MSN LABORATORIES #1 Buyer: MSN LABS

Who Supplies Pomalidomide? Top Manufacturers & Buyers 2026 — MSN LABORATORIES PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1MSN LABORATORIES PRIVATE LIMITED

MSN LABORATORIES PRIVATE LIMITED is the first-largest Pomalidomide exporter from India, with a market share of 62.6% and a total export value of $2.8M across 19 shipments. Their average shipment value of $145.4K is above the market average of $6.7K, suggesting premium or bulk contract pricing.

MSN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. MSN LABS AMERICAS SASNIT is the dominant customer, accounting for 54.0% of this supplier's tracked business. Top customers include:

• MSN LABS AMERICAS SASNIT — $1.5M across 10 shipments (54.0% of this supplier's total exports)

• MSN LABS PERU SAC — $454.2K across 3 shipments (16.4% of this supplier's total exports)

• TO THE ORDER MSN LAB — $447.6K across 3 shipments (16.2% of this supplier's total exports)

• MSN LABS AMERICAS SASNIT — $197.5K across 1 shipments (7.1% of this supplier's total exports)

• TO THE ORDER OF — $170.9K across 1 shipments (6.2% of this supplier's total exports)

Key Insight: MSN LABORATORIES PRIVATE LIMITED's per-shipment value of $145.4K is 2081% above the market average of $6.7K, consistent with large-order contracts or value-added formulations.

2NATCO PHARMA LIMITED

NATCO PHARMA LIMITED is the second-largest Pomalidomide exporter from India, with a market share of 21.9% and a total export value of $967.6K across 5 shipments. Their average shipment value of $193.5K is above the market average of $6.7K, suggesting premium or bulk contract pricing.

NATCO PHARMA LIMITED serves 1 named buyer in our database. AIMANT FZC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• AIMANT FZC — $967.6K across 5 shipments (100.0% of this supplier's total exports)

Key Insight: NATCO PHARMA LIMITED's per-shipment value of $193.5K is 2803% above the market average of $6.7K, consistent with large-order contracts or value-added formulations.

3VISHAKHA IMPEX

VISHAKHA IMPEX is the third-largest Pomalidomide exporter from India, with a market share of 1.2% and a total export value of $51.8K across 25 shipments. Their average shipment value of $2.1K is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.

VISHAKHA IMPEX serves 1 named buyer in our database. STR INTERNATIONAL TRADING CO., LTD is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• STR INTERNATIONAL TRADING CO., LTD — $51.8K across 25 shipments (100.0% of this supplier's total exports)

Key Insight: VISHAKHA IMPEX operates with high shipment frequency (25 shipments) at a per-shipment value of $2.1K, indicating a broad distribution network with many smaller, regular orders.

43S PHARMACEUTICALS INDIA PRIVATE LIMITED

3S PHARMACEUTICALS INDIA PRIVATE LIMITED is the fourth-largest Pomalidomide exporter from India, with a market share of 0.7% and a total export value of $32.3K across 14 shipments. Their average shipment value of $2.3K is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.

3S PHARMACEUTICALS INDIA PRIVATE LIMITED serves 2 named buyers in our database. XXTERXXFZCX is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• XXTERXXFZCX — $32.3K across 14 shipments (100.0% of this supplier's total exports)

• TO M S MAKIZ PHARMA — $0 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: 3S PHARMACEUTICALS INDIA PRIVATE LIMITED operates with high shipment frequency (14 shipments) at a per-shipment value of $2.3K, indicating a broad distribution network with many smaller, regular orders.

53S CORPORATION

3S CORPORATION is the fifth-largest Pomalidomide exporter from India, with a market share of 0.5% and a total export value of $23.3K across 48 shipments. Their average shipment value of $485 is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.

3S CORPORATION serves 4 named buyers in our database. ALQUIMIA LIMITED (COOKST PHARMACY) is the dominant customer, accounting for 65.9% of this supplier's tracked business. Top customers include:

• ALQUIMIA LIMITED (COOKST PHARMACY) — $15.3K across 32 shipments (65.9% of this supplier's total exports)

• ALQUIMIA LIMITED — $3.2K across 7 shipments (13.8% of this supplier's total exports)

• ALQUIMIA LIMITED (COOKST PHARMACY) — $3.1K across 6 shipments (13.5% of this supplier's total exports)

• ALQUIMIA LTD — $1.6K across 3 shipments (6.8% of this supplier's total exports)

Key Insight: 3S CORPORATION operates with high shipment frequency (48 shipments) at a per-shipment value of $485, indicating a broad distribution network with many smaller, regular orders.

6HETERO LABS LIMITED

HETERO LABS LIMITED is the fifth-largest Pomalidomide exporter from India, with a market share of 0.0% and a total export value of $217 across 7 shipments. Their average shipment value of $31 is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.

HETERO LABS LIMITED serves 1 named buyer in our database. JUNO PHARMACEUTICALS is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• JUNO PHARMACEUTICALS — $217 across 7 shipments (100.0% of this supplier's total exports)

Key Insight: HETERO LABS LIMITED operates with high shipment frequency (7 shipments) at a per-shipment value of $31, indicating a broad distribution network with many smaller, regular orders.

1Colombia

Colombia ranks as the first-largest destination for Pomalidomide imports from India, with a total trade value of $2.2M across 5 shipments — representing a 50.5% share of all Pomalidomide exports. The average shipment value of $445.2K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Pomalidomide importers in Colombia: MSN LABS AMERICAS SAS is the largest buyer, accounting for 67.0% ($1.5M) of this market's total imports.

• MSN LABS AMERICAS SAS — $1.5M (67.0% of Colombia's total)

• MSN LABS AMERICAS SASNIT — $197.5K (8.9% of Colombia's total)

Key Insight: Colombia's per-shipment average of $445.2K (6580% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Colombia is a key market for Pomalidomide imports from India.

Primary Market

Secondary Market

2United Arab Emirates

United Arab Emirates ranks as the second-largest destination for Pomalidomide imports from India, with a total trade value of $1.1M across 4 shipments — representing a 25.1% share of all Pomalidomide exports. The average shipment value of $277.3K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Pomalidomide importers in United Arab Emirates: AIMANT FZC is the largest buyer, accounting for 87.2% ($967.6K) of this market's total imports.

• AIMANT FZC — $967.6K (87.2% of United Arab Emirates's total)

• WORLD HEALTH ORGANIZATION WAREHOUSE — $121.0K (10.9% of United Arab Emirates's total)

Key Insight: United Arab Emirates's per-shipment average of $277.3K (4061% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Arab Emirates is a key market for Pomalidomide imports from India.

Primary Market

Secondary Market

3Peru

Peru ranks as the third-largest destination for Pomalidomide imports from India, with a total trade value of $658.9K across 8 shipments — representing a 14.9% share of all Pomalidomide exports. The average shipment value of $82.4K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Pomalidomide importers in Peru: MSN LABS PERU SAC is the largest buyer, accounting for 68.9% ($454.2K) of this market's total imports.

• MSN LABS PERU SAC — $454.2K (68.9% of Peru's total)

• DIDRSASR DISTRIBUIDORA DROGUERIA SAGITARIO SRL — $19.0K (2.9% of Peru's total)

Key Insight: Peru's per-shipment average of $82.4K (1136% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Peru is a key market for Pomalidomide imports from India.

Primary Market

Secondary Market

4Thailand

Thailand ranks as the fourth-largest destination for Pomalidomide imports from India, with a total trade value of $69.2K across 3 shipments — representing a 1.6% share of all Pomalidomide exports. The average shipment value of $23.1K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Pomalidomide importers in Thailand: STR INTERNATIONAL TRADING CO., LTD is the largest buyer, accounting for 96.3% ($66.6K) of this market's total imports.

• STR INTERNATIONAL TRADING CO., LTD — $66.6K (96.3% of Thailand's total)

Key Insight: Thailand's per-shipment average of $23.1K (246% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Thailand is a key market for Pomalidomide imports from India.

Primary Market

Secondary Market

5Canada

Canada ranks as the fifth-largest destination for Pomalidomide imports from India, with a total trade value of $64.3K across 4 shipments — representing a 1.5% share of all Pomalidomide exports. The average shipment value of $16.1K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Pomalidomide importers in Canada: NATCO PHARMA (CANADA) INC is the largest buyer, accounting for 100.0% ($64.3K) of this market's total imports.

• NATCO PHARMA (CANADA) INC — $64.3K (100.0% of Canada's total)

Key Insight: Canada's per-shipment average of $16.1K (141% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Pomalidomide imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Pomalidomide.
2.Flow Mapping: 108 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 662 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 52 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

662 Verified Shipments

108 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Pomalidomide

Pomalidomide

Who Supplies Pomalidomide? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Pomalidomide? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Pomalidomide Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MSN LABORATORIES PRIVATE LIMITED

2NATCO PHARMA LIMITED

3VISHAKHA IMPEX

43S PHARMACEUTICALS INDIA PRIVATE LIMITED

53S CORPORATION

6HETERO LABS LIMITED

From Indian Factories to Global Pharmacies — How Pomalidomide Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Pomalidomide Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Colombia

2United Arab Emirates

3Peru

4Thailand

5Canada

People Also Ask — Pomalidomide Supplier & Trade Network

Pomalidomide Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology